| 英文别名： |
halcinonide;21-chloro-9-alpha-fluoro-11-beta-hydroxy-16-alpha,17-alpha-isopropylidenedioxypregn-4-ene-3,20-dione;Alcinonide;Halciderm;Halcimat;halcinomide;Halog;UNII-SI86V6QNEG;(11b,16a)-21-Chloro-9-fluoro-11-hydroxy-16,17-[(1-methylethylidene)bis(oxy)]-pregn-4-ene-3,20-dione;Halcinonide;AC-1114;D07AD02;HALCINONIDE [WHO-DD];HALOG-E;CCG-220655;DTXSID6045375;HALCINONIDE [USP-RS];Halcinonide Topical;SPBio_002610;HY-B0877;EN300-7409331;Pregn-4-ene-3,20-dione, 21-chloro-9-fluoro-11-hydroxy-16,17-((1-methylethylidene)bis(oxy))-,(11beta,16alpha)-;HALCINONIDE [ORANGE BOOK];BSPBio_000689;5-19-06-00301 (Beilstein Handbook Reference);Pregn-4-ene-3,20-dione,21-chloro-9-fluoro-11-hydroxy-16,17-[(1-methylethylidene)bis(oxy)]-,(11b,16a)-;EINECS 221-439-6;(4R,8S)-8-(2-Chloroacetyl)-12-fluoro-11-hydroxy-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icos-17-en-16-one;DTXCID4025375;Halog (TN);HALCINONIDE (USP MONOGRAPH);Ascochrom;CHEBI:31663;Halcinonida [INN-Spanish];NCGC00016621-01;H1672;HMS2097C11;HALCINONIDE [USAN];(1S,2S,4R,8S,9S,11S,12R,13S)-8-(2-chloroacetyl)-12-fluoro-11-hydroxy-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icos-17-en-16-one;NS00008730;Tox21_110530_1;CAS-3093-35-4;CHEMBL1200845;Halcinonide [USAN:USP:INN:BAN:JAN];Halcinonida;Prestwick1_000655;3093-35-4;AC-1774;Prestwick_1069;Halcinonidum (INN-Latin);D01308;Halcinonid;Halcinonidum;NSC 758413;Halcinonide Cream;SQ 18566;Prestwick0_000655;C74589;Prestwick2_000655;HALCINONIDE [INN];s4098;HMS2230O07;Pregn-4-ene-3,20-dione, 21-chloro-9-fluoro-11-hydroxy-16,17-((1-methylethylidene)bis(oxy))-, (11beta,16alpha)-;SQ-18,566;HALCINONIDE (USP-RS);SQ-18566;DB06786;SI86V6QNEG;Pregn-4-ene-3,20-dione, 21-chloro-9-fluoro-11-beta,16-alpha,17-trihydroxy-, cyclic16,17-acetal with acetone;Volog;HALCINONIDE [MART.];Betacorton;Halcinonidum [INN-Latin];BRD-K81709173-001-03-8;BPBio1_000759;SCHEMBL4335;NCGC00179475-01;HALCINONIDE (MART.);MLS002153935;(1S,2S,4R,8S,9S,11S,12R,13S)-8-(2-chloroacetyl)-12-fluoro-11-hydroxy-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icos-17-en-16-one;Q-201180;Halcinonide, United States Pharmacopeia (USP) Reference Standard;(4aS,4bR,5S,6aS,6bS,9aR,10aS,10bS)-6b-(chloroacetyl)-4b-fluoro-5-hydroxy-4a,6a,8,8-tetramethyl-3,4,4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-tetradecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one;N6-(Trifluoroacetyl)-L-lysyl-L-proline;(1S,2S,4R,8S,9S,11S,12R,13S)-8-(2-CHLOROACETYL)-12-FLUORO-11-HYDROXY-6,6,9,13-TETRAMETHYL-5,7-DIOXAPENTACYCLO[10.8.0.0(2),?.0?,?.0(1)(3),(1)?]ICOS-17-EN-16-ONE;SO-18566;Halcinonida (INN-Spanish);AKOS015962797;HALCINONIDE [VANDF];NCGC00179475-03;Tox21_110530;(4aS,4bR,5S,6aS,6bS,9aR,10aS,10bS)-6b-(chloroacetyl)-4b-fluoro-5-hydroxy-4a,6a,8,8-tetramethyl-3,4,4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-tetradecahydro-2H-naphtho(2',1':4,5)indeno(1,2-d)(1,3)dioxol-2-... |
沪公网安备 
